Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study

Abstract

Atrial fibrillation (AF) causes a third of all strokes, but often goes undetected before stroke. Identification of unknown AF in the community and subsequent anti-thrombotic treatment could reduce stroke burden. We investigated community screening for unknown AF using an iPhone electrocardiogram (iECG) in pharmacies, and determined the cost-effectiveness of this strategy.Pharmacists performedpulse palpation and iECG recordings, with cardiologist iECG over-reading. General practitioner review/12-lead ECG was facilitated for suspected new AF. An automated AF algorithm was retrospectively applied to collected iECGs. Cost-effectiveness analysis incorporated costs of iECG screening, and treatment/outcome data from a United Kingdom cohort of 5,555 patients with incidentally detected asymptomatic AF. A total of 1,000 pharmacy customers aged ≥65 years (mean 76 ± 7 years; 44% male) were screened. Newly identified AF was found in 1.5% (95% CI, 0.8-2.5%); mean age 79 ± 6 years; all had CHA2DS2-VASc score ≥2. AF prevalence was 6.7% (67/1,000). The automated iECG algorithm showed 98.5% (CI, 92-100%) sensitivity for AF detection and 91.4% (CI, 89-93%) specificity. The incremental cost-effectiveness ratio of extending iECG screening into the community, based on 55% warfarin prescription adherence, would be $AUD5,988 (€3,142; $USD4,066) per Quality Adjusted Life Year gained and $AUD30,481 (€15,993; $USD20,695) for preventing one stroke. Sensitivity analysis indicated cost-effectiveness impro…

Overview

Integrity signals

Registry

Crossref · 10.1160/th14-03-0231

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 48 references

Research works printed but not linked: 2

  1. National Collaborating Centre for Chronic Conditions, 2006, Atrial fibrillation: national clinical guideline for management in primary and secondary care
  2. AS Vestergaard, 2013, A health economic evaluation of stroke prevention in atrial fibrillation – current treatment practice versus guideline adherence in Denmark [Masters Thesis]

Cited by

See all 480

Metadata

Authors
Lowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., Wallenhorst, C., Lau, J. K., Brieger, D. B., Sy, R. W., & Freedman, S. B.
Affiliations
  • The University of Sydney (AU)
  • The University of Western Australia (AU)
Venue
Thrombosis and Haemostasis
Published
2014
Volume
111
Issue
06
Pages
1167-1176
ISSN
  • 0340-6245 (ISSN-L)
  • 2567-689X
OpenAlex
W1616073113
Cited by
458
References
48
Citations by year
2026: 14 · 2025: 15 · 2024: 14 · 2023: 22 · 2022: 40 · 2021: 57 · 2020: 52 · 2019: 44 · 2018: 58 · 2017: 52 · 2016: 48 · 2015: 28 · 2014: 14
FWCI
32.46
Type
journal article
Language
en
Open access
closed
Locations
  • Thrombosis and Haemostasis (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Research Online (University of Wollongong) (submittedVersion)
  • Edinburgh Napier Research Repository (Edinburgh Napier University) (submittedVersion)
Funders
  • Bristol-Myers Squibb/Pfizer
  • Boehringer Ingelheim
  • Bayer
  • Career Development and Future Leader Fellowship
  • NHMRC and National Heart Foundation (APP1061793)
  • NHMRC early career fellow (APP1036763)
  • National Heart Foundation Postgraduate Scholarship (PP12S6990)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
atrial fibrillation, stroke prevention, community-based screening, cost-effectiveness, thromboembolic risk, CHA2DS2-VASc score, older adults
MeSH terms
Aged, Aged, 80 and over, Algorithms, Atrial Fibrillation, Community Health Services, Cost-Benefit Analysis, Cross-Sectional Studies, Diagnosis, Computer-Assisted, Electrocardiography, Female, Humans, Male, Mass Screening, New South Wales, Pharmacies, Pharmacists, Prevalence, Quality-Adjusted Life Years, Stroke, Cell Phone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study. https://app.cochat.ai/papers/10.1160/th14-03-0231
The paper
Lowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., Wallenhorst, C., Lau, J. K., Brieger, D. B., Sy, R. W., & Freedman, S. B. (2014). Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study. Thrombosis and Haemostasis. https://doi.org/10.1160/th14-03-0231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.